# 2026-10084: VA Expands Access to State Drug Monitoring Data

2026-10084, Expanding Access to State Prescription Drug Monitoring Programs, is a Federal Register proposed rule from Veterans Affairs Department published 2026-05-20, effective Comments must be received on or before July 20, 2026.; PRIA reads it as touching household money (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2026-10084
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-10084
- Title: Expanding Access to State Prescription Drug Monitoring Programs
- Type: Proposed Rule
- Agencies: Veterans Affairs Department
- Citation: 91 FR 29407
- Published: 2026-05-20
- Effective: Comments must be received on or before July 20, 2026.
- Comments close: 2026-07-20
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: 2900-AS73
- Last updated: 2026-06-11

## In one line

VA Expands Access to State Drug Monitoring Data

## Summary

The VA is making it easier and clearer for certain VA health workers to check State Prescription Drug Monitoring Programs (PDMPs) to keep an eye on prescription drug use. This change helps prevent medicine misuse and protects those checking the data while they do their jobs. Comments on this new rule are open until July 20, 2026, and it aims to make prescribing safer for veterans.

## Abstract

The Department of Veterans Affairs (VA) proposes to amend its regulation that governs disclosure of information to and querying of State prescription drug monitoring programs (PDMPs). The rule would clarify certain statutory definitions, including the definition of delegate and licensed health care provider. In doing so, VA would eliminate confusion as to who VA would allow to query the PDMP and would better protect these individuals from any possible adverse action by a State, as long as they are acting within the scope of their VA employment or, if applicable, scope of their contract. The rule would also mandate that VA disclose the specified information to State PDMPs to the extent necessary to prevent misuse and diversion of prescription medicines. This proposed rule would promote safe and effective prescribing of controlled substances to covered individuals and patients who receive VA health care.

## Effects PRIA read

- VA must send specific PDMP data: benefit, low. VA will be required to disclose specified information to State prescription drug monitoring programs (PDMPs) to the extent necessary to prevent misuse and diversion of prescription medicines. The rule lists the types of information VA will disclose, including demographic data (for example, name, ad…
- VA providers are authorized PDMP users: benefit, medium. VA licensed health care providers and delegates are deemed authorized users who may query and receive PDMP data nationwide, irrespective of conflicting State laws. The rule also says no State may deny or revoke a license, registration, or certification of such a provider or delegate solely because…
- Broader definition of VA delegates: benefit, low. VA expands and clarifies who counts as a 'delegate' that may access PDMPs when acting under the direction or supervision of a licensed VA health care provider. Delegates explicitly include VA clinical associates (for example, registered nurses), VA administrative associates (for example, technical…
- Automated PDMP queries and interoperability allowed: benefit, low. VA expressly allows querying PDMPs through manual access or integrated, potentially automated, IT systems such as health information exchanges, electronic health records, and e-prescribing, and it defines interoperability to include PDMP integration with EHRs and linking PDMPs to other State data s…
- Palliative/hospice patients and PDMP coverage: mixed, low. The rule notes that section 1730B(b)(2) excludes individuals receiving palliative care or enrolled in hospice from the statutory definition of 'covered patients.' It also states VA licensed providers and delegates may still access State PDMPs for such patients when States allow access.

## Related documents

- [2026-11973](https://policyrisk.com/federal-register/2026-11973): Implementing Regulation for National Environmental Policy Act (NEPA): Environmental Effects of the Department of Veterans Affairs Actions, 2026-06-15
- [2026-03940](https://policyrisk.com/federal-register/2026-03940): Rescission of Interim Final Rule, Evaluative Rating: Impact of Medication, 2026-02-27
- [2025-21242](https://policyrisk.com/federal-register/2025-21242): Extending Deadline for Debtor To Request a Waiver, 2025-11-26
- [2025-18827](https://policyrisk.com/federal-register/2025-18827): Extension of Program of Comprehensive Assistance for Family Caregivers Eligibility for Legacy Participants and Legacy Applicants, 2025-09-29
- [2025-14687](https://policyrisk.com/federal-register/2025-14687): Reproductive Health Services, 2025-08-04
- [2026-22391](https://policyrisk.com/federal-register/2026-22391): Agency Information Collection Activity: Application for Cash Surrender, Application for Policy Loan, Application for Cash Surrender, 2026-11-03

## Sources
- [2026-10084 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/20/2026-10084/expanding-access-to-state-prescription-drug-monitoring-programs)
- [2026-10084 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-20/pdf/2026-10084.pdf)

## Related
- [Previous: 2026-10082, Increasing the Fee for Certain Aliens Ordered Removed in Absentia as Establishe…](https://policyrisk.com/federal-register/2026-10082)
- [Next: 2026-10085, Rescission of Regulatory Determinations and Removal of Related Provisions for F…](https://policyrisk.com/federal-register/2026-10085)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-10084 (as of 2026-06-11).
